Lewy body-related alpha-synucleinopathy in aging.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Journal of Neuropathology and Experimental Neurology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 15290899
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuropathological stageing of Alzheimer-related changes

  2004cited by this paper
• Distinctive, rapid, and easy labeling of diffuse plaques in the Alzheimer brains by a new methenamine silver stain

  2004cited by this paper
• α-Synuclein pathology in Parkinson’s and Alzheimer’s disease brain: incidence and topographic distribution—a pilot study

  2003cited by this paper
• Regional distribution of alpha-synuclein pathology in unimpaired aging and Alzheimer disease.

  2003cited by this paper
• Staging of brain pathology related to sporadic Parkinson's disease.

  2003cited by this paper
• Accumulation of phosphorylated alpha-synuclein in aging human brain.

  2003cited by this paper
• alpha-Synuclein is phosphorylated in synucleinopathy lesions.

  2002cited by this paper
• Severe Involvement of Ambient Gyrus in Dementia with Grains

  2002cited by this paper
• Promoter polymorphisms of human paraoxonase PON1 gene and serum paraoxonase activities and concentrations.

  2000cited by this paper
• A polymorphism upstream from the human paraoxonase (PON1) gene and its association with PON1 expression.

  2000cited by this paper
• Apolipoprotein E epsilon4 allele and progression of cortical Lewy body pathology in Parkinson's disease.

  1998cited by this paper
• Dementia with Grains (Argyrophilic Grain Disease)

  1998cited by this paper
• Senile Dementia with Tangles (Tangle Predominant Form of Senile Dementia)

  1998cited by this paper
• Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.

  1997cited by this paper
• Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB)

  1996cited by this paper
• Apolipoprotein E genotype and Lewy body disease

  1995cited by this paper
• Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease.

  1994cited by this paper
• Vascular dementia

  1993cited by this paper
• The molecular basis of the human serum paraoxonase activity polymorphism

  1993cited by this paper
• The Consortium to Establish a Registry for Alzheimer's Disease (CERAD)

  1991cited by this paper
• A New Clinical Scale for the Staging of Dementia

  1982cited by this paper
• Silver staining of Alzheimer's neurofibrillary changes by means of physical development.

  1971cited by this paper

• AAV-mediated intracerebral expression of an α-synuclein-targeting intrabody improves motor functions in aged rats

  2026cites this paper
• Identifying individuals at-risk of developing Parkinson’s disease using a population-based recruitment strategy: The Healthy Brain Ageing Kassel Study

  2025cites this paper
• Deciphering the Janus‐Faced Nature of the Apolipoprotein Superfamily in Parkinsonian Neurodegeneration: Molecular Crosstalk Between the Astroglial Secretome and Neuronal Homeostasis

  2025cites this paper
• Pathological Characterisation of Posterior Cortical Atrophy in Comparison With Amnestic Alzheimer's Disease

  2025influential citation
• Towards a better diagnosis and treatment of dementia: Identifying common and distinct neuropathological mechanisms in Alzheimer's and vascular dementia.

  2025cites this paper
• A Novel PINK1 p.F385S Loss‐of‐Function Mutation in an Indian Family with Parkinson's Disease

  2024cites this paper
• Age-Related Pathology in Corticobasal Degeneration

  2024cites this paper
• Towards a biological diagnosis of PD.

  2024cites this paper
• Conjugal Synucleinopathies: A Clinicopathologic Study

  2024cites this paper
• Primary cilia in Parkinson’s disease: summative roles in signaling pathways, genes, defective mitochondrial function, and substantia nigra dopaminergic neurons

  2024cites this paper
• Neuropathological changes associated with aberrant cerebrospinal fluid p-tau181 and Aβ42 in Alzheimer’s disease and other neurodegenerative diseases

  2024cites this paper
• Right anterior insula ASL hypoperfusion as a diagnostic biomarker of prodromal and mild dementia with Lewy bodies: preliminary evidence using a Bayesian approach

  2024cites this paper
• Neuropathology of incidental Lewy body & prodromal Parkinson’s disease

  2023cites this paper
• Morphological study of the phrenic nerve to determine a reference value for the myelinated fiber density in elderly individuals

  2022cites this paper
• Macroscopic diagnostic clue for parkinsonism

  2022cites this paper
• Characterizing Lewy Pathology in 231 Essential Tremor Brains From the Essential Tremor Centralized Brain Repository.

  2022cites this paper
• Phosphorylated alpha‐synuclein in Iba1‐positive macrophages in the skin of patients with Parkinson's disease

  2022cites this paper
• One Autopsy Proved Neocortical Lewy Body Disease Without the Involvement of the Olfactory Bulb and Brainstem

  2022cites this paper
• Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease

  2022cites this paper
• Unique Lewy pathology in myotonic dystrophy type 1

  2022cites this paper
• A Comprehensive Study of miRNAs in Parkinson's Disease: Diagnostics and Therapeutic Approaches.

  2022cites this paper
• An autopsied case report of spastic paraplegia with thin corpus callosum carrying a novel mutation in the SPG11 gene: widespread degeneration with eosinophilic inclusions

  2022cites this paper
• The Logic and Pitfalls of Parkinson's Disease as “Brain‐First” Versus “Body‐First” Subtypes

  2021cites this paper
• Neuropathological evidence of body-first vs. brain-first Lewy body disease.

  2021cites this paper
• Lewy pathology of the submandibular gland in Lewy body disease: A report of autopsy cases

  2021cites this paper
• An autopsy case of PARK2 due to a homozygous exon 2 deletion of parkin and associated with α‐synucleinopathy

  2021influential citation
• Where and how alpha‐synuclein pathology spreads in Parkinson’s disease:

  2020cites this paper
• Implications of the Gut Microbiome in Parkinson's Disease

  2020cites this paper
• Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases

  2020cites this paper
• Sex-dependent effect of APOE on Alzheimer's disease and other age-related neurodegenerative disorders

  2020cites this paper
• The development and convergence of co-pathologies in Alzheimer's disease.

  2020cites this paper
• Clinicopathological overlap of neurodegenerative diseases: A comprehensive review.

  2020cites this paper
• Neuroimaging and neuropathological findings in essential tremor

  2019cites this paper
• Unified Staging System for Lewy Body Disorders: Clinicopathologic Correlations and Comparison to Braak Staging.

  2019cites this paper
• The Contribution of Tau, Amyloid-Beta and Alpha-Synuclein Pathology to Dementia in Lewy Body Disorders

  2018cites this paper
• Olfactory Dysfunction in Neurodegenerative Diseases

  2018cites this paper
• How does parkinson's disease begin? Perspectives on neuroanatomical pathways, prions, and histology

  2018cites this paper
• Alpha-synucleinopathies.

  2017cites this paper
• Does Parkinson’s disease start in the gut?

  2017cites this paper
• Improved diagnosis of Parkinson's disease from a detailed olfactory phenotype

  2017cites this paper
• Assessment of the visual thalamic circuitry in hallucinations in dementia with Lewy bodies

  2017cites this paper
• Aszensionshypothese beim idiopathischen Parkinson-Syndrom

  2017cites this paper
• Gastrointestinal Symptoms and Olfactory Disorder as Prodromal Non-motor Symptoms of Idiopathic Parkinson’s Disease compa-Hypothesis of Ascension in Idiopathic Parkinson ’ s Disease

  2017cites this paper
• Neuropathology of Nonmotor Symptoms of Parkinson's Disease.

  2017cites this paper
• Gastrointestinal Symptoms and Olfactory Disorder as Prodromal Non-motor Symptoms of Idiopathic Parkinson’s Disease compa-Hypothesis of Ascension in Idiopathic Parkinson ’ s Disease

  2017cites this paper
• DJ-1 as a Biomarker of Parkinson's Disease.

  2017cites this paper
• Relationship between Apolipoprotein Superfamily and Parkinson's Disease

  2017cites this paper
• Gastrointestinal Symptoms and Olfactory Disorder as Prodromal Non-motor Symp- toms of Idiopathic Parkinson’s Disease

  2017cites this paper
• α-Synuclein aggregation in the olfactory bulb of middle-aged common marmoset.

  2016cites this paper
• Propagated but Topologically Distributed Forebrain Neurons Expressing Alpha-Synuclein in Aged Macaques

  2016influential citation
• Lewy body pathology involves the olfactory cells in Parkinson's disease and related disorders

  2016cites this paper
• Progressive supranuclear palsy and Parkinson's disease overlap: A clinicopathological case report

  2016cites this paper
• Neuropathological basis of nonmotor manifestations of Parkinson's disease

  2016cites this paper
• Neuroimaging correlates of blinking abnormalities in patients with progressive supranuclear palsy

  2016cites this paper
• Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson’s disease patients

  2016cites this paper
• Histopathologic Analysis of Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL): A Report of a New Genetically Confirmed Case and Comparison to 2 Previous Cases

  2016cites this paper
• Early Stage of Progressive Supranuclear Palsy: A Neuropathological Study of 324 Consecutive Autopsy Cases.

  2015cites this paper
• Distribution of α-synuclein in the spinal cord and dorsal root ganglia in an autopsy cohort of elderly persons

  2015cites this paper
• Incidence and extent of TDP-43 accumulation in aging human brain

  2015cites this paper
• Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors

  2015cites this paper
• Increased oligomerization and phosphorylation of α-synuclein are associated with decreased activity of glucocerebrosidase and protein phosphatase 2A in aging monkey brains.

  2015influential citation
• Long-term health of dopaminergic neuron transplants in Parkinson's disease patients.

  2014cites this paper
• Increased striatal adenosine A2A receptor levels is an early event in Parkinson's disease-related pathology and it is potentially regulated by miR-34b.

  2014cites this paper
• Functional characterization of HtrA2 in the pathogenesis of Parkinson´s disease

  2014cites this paper
• N-Terminal Truncated UCH-L1 Prevents Parkinson's Disease Associated Damage

  2014cites this paper
• Alpha-synuclein immunohistochemistry of gastrointestinal and biliary surgical specimens for diagnosis of Lewy body disease.

  2014cites this paper
• MIBG myocardial scintigraphy in pre-motor Parkinson's disease: a review.

  2014cites this paper
• Immunostaining of Oxidized DJ-1 in Human and Mouse Brains

  2014cites this paper
• α‐Synuclein oligomers and clinical implications for Parkinson disease

  2013cites this paper
• Extensive aggregation of α-synuclein and tau in juvenile-onset neuroaxonal dystrophy: an autopsied individual with a novel mutation in the PLA2G6 gene-splicing site

  2013cites this paper
• 100 years of Lewy pathology

  2013cites this paper
• [Essential tremor and Parkinson's disease: are they associated? Reply].

  2013cites this paper
• Neuropathologic Correlates of Cognition in a Population-Based Sample

  2013cites this paper
• Upregulation of a small vault RNA (svtRNA2-1a) is an early event in Parkinson disease and induces neuronal dysfunction

  2013cites this paper
• Temblor esencial y enfermedad de Parkinson:: ¿existe una asociación?

  2013cites this paper
• Lack of Association of Apolipoprotein E ɛ4 Genotype with Cognitive Dysfunction in Essential Tremor

  2013cites this paper
• Parkinson-Syndrom(e) – Neue Konzepte für eine sich ausbreitende Erkrankung?

  2013cites this paper
• Neuropathologic analysis of Lewy‐related α‐synucleinopathy in olfactory mucosa

  2013cites this paper
• The current consensus criteria for the neuropathologic diagnosis of Alzheimer ’ s disease ( AD ) , known as the National Institute on Aging / Reagan Institute of the Alzheimer Association Consensus Recommendations for the Postmortem Diagnosis of AD or

  2013cites this paper
• Lewy pathology and neurodegeneration in premotor Parkinson's disease

  2012cites this paper
• National Institute on Aging–Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease

  2012cites this paper
• Interaction between pathogenic proteins in neurodegenerative disorders

  2012cites this paper
• Bilaterales Zittern der Hände häufig nicht diagnostiziert

  2012cites this paper
• Biochemical Increase in Phosphorylated Alpha‐Synuclein Precedes Histopathology of Lewy‐Type Synucleinopathies

  2012cites this paper
• Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease?

  2012cites this paper
• Neurochemistry and the non-motor aspects of PD.

  2012cites this paper
• Lewy body‐related α‐synucleinopathy in the spinal cord of cases with incidental Lewy body disease

  2012cites this paper
• Neuropathology of sporadic Parkinson's disease: Evaluation and changes of concepts

  2012cites this paper
• Severe Alterations in Lipid Composition of Frontal Cortex Lipid Rafts from Parkinson’s Disease and Incidental Parkinson’s Disease

  2011cites this paper
• MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.

  2011influential citation
• Synuclein deposition and non-motor symptoms in Parkinson disease.

  2011cites this paper
• Lewy bodies and olfactory dysfunction in old age.

  2011cites this paper
• NATIONAL INSTITUTE ON AGING – ALZHEIMER ’ S ASSOCIATION GUIDELINES FOR THE NEUROPATHOLOGIC ASSESSMENT OF ALZHEIMER ’ S DISEASE DRAFT 8 JULY , 2011

  2011cites this paper
• Findings that shed new light on the possible pathogenesis of a disease or an adverse effect Superfi cial siderosis associated with abundant τ and α-synuclein accumulation

  2011cites this paper
• Essential tremor and Parkinson's disease: Lack of a link

  2011influential citation
• Neuropathology underlying clinical variability in patients with synucleinopathies

  2011cites this paper
• Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218.

  2011cites this paper
• Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease

  2011cites this paper
• Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein

  2011cites this paper
• National Institute on Aging–Alzheimer’s Association guidelines for the neuropathologic assessment of Alzheimer’s disease: a practical approach

  2011cites this paper